Stille
237 SEK +1.72%6 investors are following this company
Stille develops, manufactures, and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology, and urology. The company's products are used among users on a global level. In addition to the core business, instrument management training is also offered. Stille was originally founded in 1841 and is headquartered in Eskilstuna.
Revenue
-
EBIT %
-
P/E
44.63
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
STIL
Daily low / high price
231 / 244
SEK
Market cap
2.13B SEK
Turnover
712.67K SEK
Volume
3K
Financial calendar
Interim report
24.10.2024
Annual report
13.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Impilo AB | 22.9 % | 22.9 % |
Linc AB | 22.9 % | 22.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Redeye: Stille Q2 2024 - In line with estimates
Stille AB: Interim Report Q2 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools